Introduction
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Overview
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Therapeutics Development
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Therapeutics Assessment
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Companies Involved in Therapeutics Development
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Drug Profiles
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Dormant Projects
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Discontinued Products
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Bristol-Myers Squibb Co, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Corcept Therapeutics Inc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Enterome Bioscience SA, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Exelixis Inc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by GlaxoSmithKline Plc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Infinity Pharmaceuticals Inc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Merck & Co Inc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Merck KGaA, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Orphagen Pharmaceuticals Inc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Pharma Mar SA, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Seneca Therapeutics Inc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by TempestTx, Inc., 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline by Y-mAbs Therapeutics Inc, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Dormant Projects, 2021
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Discontinued Products, 2021

List of Figures
Number of Products under Development for Adrenocortical Carcinoma (Adrenal Cortex Cancer), 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Bristol-Myers Squibb Co
• Corcept Therapeutics Inc
• Enterome Bioscience SA
• Exelixis Inc
• GlaxoSmithKline Plc
• Infinity Pharmaceuticals Inc
• Merck & Co Inc
• Merck KGaA
• Orphagen Pharmaceuticals Inc
• Pharma Mar SA
• Seneca Therapeutics Inc
• TempestTx, Inc.
• Y-mAbs Therapeutics Inc